Evidence map›Paper›PMID 35185259›Full record

ArticleArchivos de bronconeumologia2022

Evaluation of Respiratory Sequelae in Patients With COVID-19, Where we are and Where we are Going. CIBERESUCICOVID and RECOVID Studies to Compare Patients Admitted to ICU vs Conventional Ward.

Rosario Menéndez, Adrián Ceccato, Ignacio Martín-Loeches, Ana Motos, Ferrán Barbé, Germán Peces-Barba, Laia Fernández-Barat, Jesús Bermejo-Martín, Antoni Torres

Abstract readEditorialComment
In one paragraph

Article in Archivos de bronconeumologia, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Rosario MenéndezServicio de Neumología, IIS/Hospital Universitario y Politécnico La Fe, Valencia, España; Ciber de Enfermedades Respiratorias, Madrid, España.
Adrián CeccatoCiber de Enfermedades Respiratorias, Madrid, España; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Universitat de Barcelona (UB), Barcelona, España.
Ignacio Martín-LoechesIntensive Care Medicine Unit, St. James Hospital, Dublín, Irlanda.
Ana MotosCiber de Enfermedades Respiratorias, Madrid, España; Respiratory Institute, Pulmonary Intensive Care Unit, Hospital Clínic de Barcelona, Barcelona, España.
Ferrán BarbéCiber de Enfermedades Respiratorias, Madrid, España; Group of Translational Research in Respiratory Medicine, Hospital Universitari Arnau de Vilanova y Santa María, IRB Lleida, Lleida, España.
Germán Peces-BarbaCiber de Enfermedades Respiratorias, Madrid, España; Servicio de Neumología, Fundación Jiménez Díaz, Madrid, España.
Laia Fernández-BaratCiber de Enfermedades Respiratorias, Madrid, España; Respiratory Institute, Pulmonary Intensive Care Unit, Hospital Clínic de Barcelona, Barcelona, España.
Jesús Bermejo-MartínCiber de Enfermedades Respiratorias, Madrid, España; Group For Biomedical Research in Respiratory Infectionn & Sepsis (BioSepsis), Hospital Universitario Río Hortega, Valladolid, España; IIMD23, Instituto de Investigación Biomédica de Salamanca (IBSAL), Salamanca, España.
Antoni TorresCiber de Enfermedades Respiratorias, Madrid, España; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Universitat de Barcelona (UB), Barcelona, España; Servei de Pneumologia, Institut Clinic de Respiratori, Hospital Clinic of Barcelona, Barcelona, España. Electronic address: atorres@clinic.cat.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID35185259
PMCPMC8843012

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.